Project Grant K01AI201974
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $157K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Athens, GA 30602, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded Emory University $199,044 on July 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research on mixture effects of metals and environmental chemicals on children's gut colonization with multidrug-resistant organisms. The award funds a K01 research career development project applying mixture methods—statistical approaches from exposomics—to examine the joint effects of medications,...
- The National Institute of Allergy and Infectious Diseases awarded Georgia State University Research Foundation Inc. $795,962 on August 4, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate how gut microbiota composition influences respiratory viral infection outcomes and alveolar macrophage function. The research examines the protective mechanisms by which segmented filamentous bacteria (SFB) colonization in the intestine confers resistance to severe...
- The National Institute of Allergy and Infectious Diseases awarded New York University School of Medicine $206,496 on August 19, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct genome-wide fitness analysis of Group B Streptococcus in intestinal colonization. The research uses transposon insertion sequencing to identify bacterial genes essential for gastrointestinal colonization in a murine model of postnatal Group B Streptococcus acquisition. The work...
- The National Institute of Allergy and Infectious Diseases awarded the University of Georgia Research Foundation $228,000 on July 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop enzymatic pipelines for the in vitro synthesis of parasitic glycosylphosphatidylinositol (GPI) anchors and GPI-anchored proteins. Parasitic infections affect more than one billion people globally. GPI anchors and GPI-anchored proteins are essential to parasite cell surfaces and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Georgia Research Foundation, Inc. a Project Grant totaling $415,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 21, 2025, with completion targeted for July 31, 2027. This research initiative addresses critical gaps in understanding gram-negative bacterial resistance mechanisms by investigating the feedback signaling system that...
- The National Institute of Allergy and Infectious Diseases awarded Georgia TECH Research Corp $152,600 on December 9, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate how Blastocystis, the most prevalent protist in the human gut microbiome, shapes gut ecosystem function and community structure. The research comprises three aims. Aim 1 examines how Blastocystis metabolizes dietary lipids through biochemical assays, microscopy-based trafficking analysis,...
- The National Institute of Allergy and Infectious Diseases awarded Emory University $161,244 on April 16, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct experimental evolution assays elucidating evolutionary trajectories to antibiotic resistance in Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli, and how the immune system modifies these trajectories. The research uses in vivo adaptive laboratory evolution experiments in Galleria...
- The National Institute of Allergy and Infectious Diseases awarded the University of Virginia $806,000 on May 11, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the role of secreted bacterial effectors in Group B Streptococcus (GBS) intestinal colonization and systemic neonatal infection. The research examines how GBS type VII secretion system effectors promote intestinal dysbiosis, impair immune responses, disrupt intestinal barrier function, and...
- The National Institute of Allergy and Infectious Diseases awarded the University of Georgia Research Foundation $1,023,862 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to produce and distribute filarial research reagents through the Filariasis Research Reagent Resource Center (FR3). The award funds three specific aims over a five-year period ending August 31, 2031. Under Aim 1, the recipient will ensure continued provision of high-quality...
- The National Institute of Allergy and Infectious Diseases awarded the University of Maryland, Baltimore $159,764 on June 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate gastrointestinal immune and microbiome responses to Shigella infection in children. The recipient will characterize mucosal immune markers and microbiome composition associated with susceptibility to Shigella infection in children under five years old living in low- and...